Galapagos NV (NASDAQ:GLPG)

98.62
Delayed Data
As of 2:42pm ET
 -0.72 / -0.72%
Today’s Change
72.90
Today|||52-Week Range
121.09
+5.18%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$4.9B

Company Description

Galapagos NV is a biotechnology company, which engages in the identification and development of small molecule and antibody therapies. It operates through the Research and Development and Fee-for-Services segment. The company was founded by Onno van de Stolpe, Rudi Pauwels, and Helmuth van Es on June 30, 1999 and is headquartered in Mechelen, Belgium.

Contact Information

Galapagos NV
Industriepark Mechelen Noord
Mechelen Brussels Region 2800
P:(321) 534-2900
Investor Relations:
(781) 460-1784

Employees

Shareholders

Other institutional9.61%
Mutual fund holders7.77%
Individual stakeholders--

Top Executives

Onno van de StolpeChief Executive Officer & Executive Director
Bart FiliusChief Financial Officer
Piet WigerinckChief Scientific Officer
Walid Abi-SaabChief Medical Officer
Andre HoekemaSenior Vice President-Corporate Development